Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.3698 -9.78% -0.04
TTNP closed down 9.78 percent on Thursday, September 19, 2019, on 2.67 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical TTNP trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -9.78%
Pocket Pivot Bullish Swing Setup -9.78%
Volume Surge Other -9.78%
Wide Bands Range Expansion -9.78%
Gapped Up Strength -9.78%
Oversold Stochastic Weakness -9.78%
Lower Bollinger Band Walk Weakness 9.09%
Wide Bands Range Expansion 9.09%

Older signals for TTNP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.
Pharmaceutical Chemical Compounds Organic Compounds Parkinson's Disease Schizophrenia Morphinans Opioids Buprenorphine Drug Rehabilitation Atypical Antipsychotics Chronic Conditions Fanapt Iloperidone
Is TTNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.45
52 Week Low 0.172
Average Volume 345,673
200-Day Moving Average 1.1321
50-Day Moving Average 0.7395
20-Day Moving Average 0.4131
10-Day Moving Average 0.3924
Average True Range 0.0526
ADX 48.23
+DI 16.2885
-DI 35.0496
Chandelier Exit (Long, 3 ATRs ) 0.3822
Chandelier Exit (Short, 3 ATRs ) 0.4879
Upper Bollinger Band 0.4806
Lower Bollinger Band 0.3456
Percent B (%b) 0.18
BandWidth 32.679739
MACD Line -0.095
MACD Signal Line -0.1148
MACD Histogram 0.0198
Fundamentals Value
Market Cap 7.84 Million
Num Shares 21.2 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -0.61
Price-to-Sales 259.08
Price-to-Book 6.11
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.41
Resistance 3 (R3) 0.42 0.40 0.41
Resistance 2 (R2) 0.40 0.39 0.40 0.40
Resistance 1 (R1) 0.39 0.38 0.38 0.38 0.40
Pivot Point 0.37 0.37 0.37 0.37 0.37
Support 1 (S1) 0.36 0.36 0.35 0.35 0.34
Support 2 (S2) 0.34 0.35 0.34 0.33
Support 3 (S3) 0.33 0.34 0.33
Support 4 (S4) 0.32